openPR Logo

Press Releases from DelveInsight Business Research LLP (4915 total)

NULIBRY Drug Market Forecast and Analysis | NULIBRY for Molybdenum Cofactor Defi …

(Albany, United States)//- The NULIBRY market forecast report provides an analysis of the NULIBRY market analysis and forecasts up to 2032 in the seven major

CUTX-101 Drug Market Forecast and Analysis | CUTX-101 for Menkes Diseas …

(Albany, United States)//- The CUTX-101 market forecast report provides an analysis of the CUTX-101 market analysis and forecasts up to 2032 in the seven major

Hemophilia A Market is Expected to Show a Healthy Growth Rate During the Study P …

(Las Vegas, Nevada, United States) "Hemophilia A- Market Insights, Epidemiology and Market Forecast- 2032" by DelveInsight provides a comprehensive analysis of Hemophilia A, including a

Lewy Body Disease Pipeline Assessment (2023) Covering Clinical Trials, Emerging …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in

Biliary Tract Cancers Pipeline Assessment (2023) Covering Clinical Trials, Emerg …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in

Acute Kidney Injury Pipeline Assessment (2023) Covering Clinical Trials, Emergin …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in

Adenoid Cystic Carcinoma Pipeline Assessment (2023) Covering Clinical Trials, Em …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Borderline Personality Disorders Pipeline Assessment (2023) Covering Clinical Tr …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Efgartigimod Emerging Drug Insight and Market Forecast 2032 | DelveInsight

(Las Vegas, Nevada, United States), The "Efgartigimod Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about efgartigimod for thrombocytopenia in the

Brescap Emerging Drug Insight and Market Forecast 2032 | DelveInsight

(Las Vegas, Nevada, United States), "bRESCAP Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about bRESCAP for Acute Kidney Injury (AKI)

AXS14 Emerging Drug Insight and Market Forecast 2032 | DelveInsight

(Las Vegas, Nevada, United States), The "AXS-14 Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about AXS-14 for chronic pain in

Ilofotase alfa Emerging Drug Insight and Market Forecast 2032 | DelveInsight

(Las Vegas, Nevada, United States), "Ilofotase alfa Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about ilofotase alfa for Acute Kidney

EscharEx Emerging Drug Insight and Market Forecast 2032 | DelveInsight

(Las Vegas, Nevada, United States), "EscharEx Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about EscharEx for chronic wounds in the

Diabetic Macular Edema Pipeline Assessment (2023) Covering Clinical Trials, Emer …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 60+ key pharma and biotech companies are working on 65+ pipeline drugs in

Cirrhosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapie …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in

Urinary Tract Infections Pipeline Assessment (2023) Covering Clinical Trials, Em …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 38+ key pharma and biotech companies are working on 38+ pipeline drugs in

Multiple Myeloma Pipeline Assessment (2023) Covering Clinical Trials, Emerging T …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 100+ key pharma and biotech companies are working on 130+ pipeline drugs in

Focal Segmental Glomerulosclerosis (FSGS) Pipeline Assessment (2023) Covering Cl …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 18+ pipeline drugs in

Graves' Disease Pipeline Assessment (2023) Covering Clinical Trials, Emerging Th …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 10+ pipeline drugs in

Meibomian Gland Dysfunction Pipeline Assessment (2023) Covering Clinical Trials, …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Skin Burns Market to Witness Growth During the Forecast Period (2023-32), Estima …

(Las Vegas, Nevada, United States), DelveInsight's "Skin Burns Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Skin Burns, historical and

Chronic Myelomonocytic Leukaemia Pipeline Assessment (2023) Covering Clinical Tr …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in

Methylmalonic Acidemia Pipeline Assessment (2023) Covering Clinical Trials, Emer …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Myocardial Infarction Pipeline Assessment (2023) Covering Clinical Trials, Emerg …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 60+ key pharma and biotech companies are working on 60+ pipeline drugs in

Uromune (MV140) Drug Market Forecast and Analysis | Uromune (MV140) for uncompli …

(Albany, United States)//- The Uromune (MV140) market forecast report provides an analysis of the Uromune (MV140) market analysis and forecasts up to 2032 in the

GSK2140944 (Gepotidacin) Drug Market Forecast and Analysis | GSK2140944 (Gepotid …

(Albany, United States)//- The GSK2140944 (Gepotidacin) market forecast report provides an analysis of the GSK2140944 (Gepotidacin) market analysis and forecasts up to 2032 in the

Sulopenem Etzadroxil/Probenecid Drug Market Forecast and Analysis | Sulopenem Et …

(Albany, United States)//- The Sulopenem Etzadroxil/Probenecid market forecast report provides an analysis of the Sulopenem Etzadroxil/Probenecid market analysis and forecasts up to 2032 in the

Psoriatic Arthritis Market to Witness Growth by 2032, Estimates DelveInsight | C …

DelveInsight's "Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Psoriatic Arthritis, historical and forecasted epidemiology as well as the

Inflammatory Bowel Disease market to Witness Growth by 2032 | Companies- Eli Lil …

DelveInsight's "Inflammatory Bowel Disease market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Inflammatory bowel disease, historical and forecasted epidemiology as well

Congenital Ichthyosis Pipeline Assessment (2023) Covering Clinical Trials, Emerg …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on developing various novel drugs in

Prurigo Nodularis Pipeline Assessment (2023) Covering Clinical Trials, Emerging …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Hepatic Encephalopathy Market is Expected to Showcase a Significant Growth Durin …

The Hepatic Encephalopathy Market size in the 7MM was USD 1,563 Million in 2021, which is expected to grow by 2032. Hepatic Encephalopathy Market is

Dry Age-Related Macular Degeneration (Dry AMD) Market is Predicted to Exhibit Re …

The Dry Age-Related Macular Degeneration (Dry AMD) Market size in the seven major markets was estimated to be USD 1,377 million in 2021. As

Plaque Psoriasis Market to Register Incremental Growth During the Forecast Perio …

As per DelveInsight, the Plaque Psoriasis Market is anticipated to evolve immensely in the coming years owing to the launch of new therapies, the increased

Thrombotic Thrombocytopenic Purpura Pipeline Assessment (2023) Covering Clinical …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Papulopustular Rosacea Pipeline Assessment (2023) Covering Clinical Trials, Emer …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in

Myopia Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 12+ pipeline drugs in

Endometriosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Ther …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 18+ key pharma and biotech companies are working on 25+ pipeline drugs in

Aneurysmal Subarachnoid Hemorrhage (aSAH) Pipeline Assessment (2023) Covering Cl …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 10+ pipeline drugs in

Marginal Zone Lymphoma Pipeline Assessment (2023) Covering Clinical Trials, Emer …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in

Friedreich's Ataxia Pipeline Assessment (2023) Covering Clinical Trials, Emergin …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in

Spinal Muscular Atrophy Pipeline Assessment (2023) Covering Clinical Trials, Eme …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 18+ key pharma and biotech companies are working on 20+ pipeline drugs in

Lupus Nephritis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Th …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in

Pediatric Growth Hormone Deficiency (PGHD) Market to Grow at a Substantial Growt …

DelveInsight's "Pediatric Growth Hormone Deficiency (PGHD) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology,

Weight Loss/Weight Management (Obesity) Market to Register Incremental Growth Du …

As per DelveInsight, the Weight Loss/Weight Management (Obesity) Market is anticipated to evolve immensely in the coming years owing to the increase in upcoming novel

Limb Girdle Muscular Dystrophy (LGMD) Pipeline Assessment (2023) Covering Clinic …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 25+ pipeline drugs in

Liver Fibrosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging The …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in

Liver Fibrosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging The …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in

Tourette Syndrome Pipeline Assessment (2023) Covering Clinical Trials, Emerging …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are actively working on developing novel therapies in

Glioma Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 190+ key pharma and biotech companies are working on 130+ pipeline drugs in

Go To Page:    91 92 93 94 95 96 97 98